[CAS NO. 2308510-39-4] PKD-IN-1 dihydrochloride

Ships within

Stock

Price

Qty

Total

$0.00

Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis

request a quote

If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [2308510-39-4]

Catalog

HY-131962A

Brand

MCE

CAS

2308510-39-4

DESCRIPTION [2308510-39-4]

Overview

MDL	-
Molecular Weight	415.74
Molecular Formula	C18H21Cl3N4O
SMILES	OC1=CC=C(Cl)C=C1C2=NC(NC[C@H](N)CC)=C3C=CC=CC3=N2.[H]Cl.[H]Cl

For research use only. We do not sell to patients.

Summary

PKD-IN-1 dihydrochloride (compound 32), an aminoethylamino-aryl (AEAA) compound, acts as PKD-1 inhibitor. PKD-IN-1 can be used for protein kinase D (PKD)-mediated diseases research ^[1] .

Appearance

Solid

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Solvent & Solubility

In Vitro:

DMSO : 35.71 mg/mL ( 85.90 mM ; ultrasonic and warming and heat to 60°C)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	2.4053 mL	12.0267 mL	24.0535 mL
5 mM	0.4811 mL	2.4053 mL	4.8107 mL
10 mM	0.2405 mL	1.2027 mL	2.4053 mL

* Please refer to the solubility information to select the appropriate solvent.

References

[1] RT Michael, et al. Aminoethylamino-aryl (AEAA) compounds as PKD inhibitors and their preparation, pharmaceutical compositions and use in the treatment of PKD-mediated diseases: World Intellectual Property Organization, WO2007125331. 2007-11-08.